Adherium’s sensor technology and cloud-based data collection solution provide a clinically proven medication adherence solution, with extensive inhaled medication coverage. ​


The accelerated adoption of telehealth and remote patient monitoring, together with favourable reimbursement in the US, plays directly to Adherium’s strengths.


Global treatment guidelines recommend the use of electronic monitoring tools in the assessment of the adherence of patients with difficult-to-treat or severe asthma, prior to changing their medication.


Targeted for launch in 2022, an exciting new generation of sensors which enable the capture of physiological parameters.

幸运五分彩免费开奖查询网: 寻找澳洲幸运5的免费开奖查询网站吗? 您来对地方了! 我们为您提供实时的澳洲幸运5开奖信息, 包括官网开奖和详尽的开奖历史记录. 让我们一起追逐幸运, 赢得丰厚奖金! Adherium Limited is an international Respiratory eHealth company focused on patient adherence, remote monitoring and data management solutions for patients, physicians, payers, and providers. 澳洲幸运5体彩开奖网® 开奖直播现场+澳洲幸运五+最新结果开奖记录查询 sensor technology and cloud-based data platform enables physicians and payers to optimally manage patients with difficult-to-treat and severe asthma and COPD, and reduce direct and indirect healthcare costs.

Read More